Emerging targets in human lymphoma: targeting the MYD88 mutation
James Q Wang,* Yogesh S Jeelall,* Keisuke Horikawa* Department of Immunology, The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia *All authors contributed equally to this manuscript Abstract: B cell neoplasms co-opt the molecular machinery of normal B...
Enregistré dans:
Auteurs principaux: | Wang JQ, Jeelall YS, Horikawa K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ff4e0887c6a4423ab1ae6b7efdc73c1c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
par: Farina F, et autres
Publié: (2014) -
Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021) -
Emerging role of SOX11 in mantle cell lymphoma
par: Kuci V, et autres
Publié: (2015) -
Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
par: John R. Krause, et autres
Publié: (2021)